Molecular Oncology Group, Lady Davis Institute for Medical Research, Jewish General Hospital, 3755 Cote. St. Catherine, Montreal, H3T 1E2, Canada, Tel: +1 514 340 8222 Ext. 5265, Fax: +1 514 340 7576, Email: john.hiscott@mcgill.ca
Editorial Board:
C. Basilico
NYU Medical Center, New York, NY, USA
M.V. Chao
Cornell University, New York, NY, USA
S.J. Durum
National Cancer Institute, Frederick, MD, USA
M. Feldmann
The Mathilda & Terence Kennedy Institute of Rheumatology, London, UK
T. Fujita
Kyoto University, Japan
A. Garcia-Sastre
Mount Sinai School of Medicine, New York, USA
C.-H. Heldin
Ludwig Institute Cancer Research, Uppsala, Sweden
T. Hirano
Osaka University Medical School, Osaka, Japan
C. Horvath
Northwestern University, Illinois, USA
J. Keski-Oja
University of Helsinki, Helsinki, Finland
M. Krönke
Institut für Immunologie, Kiel, Germany
W.J. Leonard
National Institutes of Health, Bethesda, MD, USA
L. O'Neill
School of Biochemistry, Trinity College Dublin, Ireland, UK
J.J. Oppenheim
National Cancer Institute, Frederick, MD, USA
R.W. Padgett
Rutgers University, Piscataway, NJ, USA
S. Pestka
UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ, USA
K. Pfizenmaier
Institute für Zellbiologie und Immunologie, Stuttgart, Germany
H.A. Reddi
University of California Davis Medical Center, Sacramento, CA, USA
C. Schindler
Columbia University, New York, USA
J. Schlessinger
Yale University School of Medicine,, New Haven, CT, USA
M. Sporn
Dartmouth Medical School, Hanover, USA
G. Trinchieri
Schering-Plough Lab of Immunological Research, Dardilly, France